MedTech Dive

Terumo has yet to establish a direct causal relationship between the deaths and the delivery system separation issues.

One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category of blood-based cancer testing.

The medtech giant said it currently has no evidence that the accessed data has been posted to the internet.

The U.S., Mexico and Canada will continue negotiating about potential adjustments to the trilateral free trade agreement, which will remain in place until at least 2036.

While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.

Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.

When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.”

Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s portfolio.

Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.

Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.

MMI built a robot to help surgeons perform microsurgical procedures with more control than is possible with the human hand alone.

The cardiac monitoring company said that a threat actor has demanded payment in exchange for not publicly releasing the stolen data.

The investment will add J&J’s manufacturing, packaging and distribution capabilities to meet growing demand for its contact lenses.

The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.

The Stelo over-the-counter glucose monitor can now be used by children as young as two years.

CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”

Why continuous audit readiness helps MedTech organizations move faster—without sacrificing confidence or control.

The Office of Health Technology and Products is the latest technology development from the CMS as it doubles down on digital tools.

Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.

The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.